 CAMBRIDGE, Mass.--BUSINESS WIRE--Epizyme, Nasdaq: EPZM, a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference call and webcast to discuss its third quarter 2020 financial results and other business highlights on Friday, Nov. 6, 2020 at 8:00 a.m. ET. To participate in the conference call, please dial 877 844-6886 domestic or 970 315-0315 international and refer to con 